{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-26-275811","form_type":"8-K","ticker":"MIRM","cik":"0001759425","company_name":"Mirum Pharmaceuticals, Inc.","filed_at":"2026-06-18T20:05:38+00:00","discovered_at":"2026-06-18T20:07:00.329497+00:00","generated_at":"2026-06-18T20:12:38.362903+00:00","sec_items":["5.07"],"event_type":"other","sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"confidence":"high","headline":"Mirum Pharma annual meeting: all director nominees elected, auditor ratified, say-on-pay approved","bullets":["Stockholders elected Lon Cardon, William Fairey, and Timothy Walbert as Class I directors with 39.6M, 40.3M, and 32.3M votes for, respectively.","Ratification of Ernst & Young as independent auditor for FY 2026 passed with 49.99M votes for, 5,674 against.","Advisory vote on executive compensation approved with 44.5M votes for, 1.87M against, and 3.6M broker non-votes.","As of record date April 20, 2026, 60,977,841 shares were outstanding and entitled to vote."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-275811","json":"https://secwatch.observer/filing/0001193125-26-275811.json","markdown":"https://secwatch.observer/filing/0001193125-26-275811.md","text":"https://secwatch.observer/filing/0001193125-26-275811.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1759425/000119312526275811/0001193125-26-275811-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1759425/000119312526275811/d74563d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-18T20:12:38.362903+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"17f5f5fe47a8585d92c80f5f88c67c10dc34afbc","claim":"Mirum Pharmaceuticals, Inc. shareholders approved Election of three Class I directors at the 2026-06-15 meeting.","evidence_excerpt":"The Company’s stockholders elected the three persons listed below as Class I directors, each to serve until the Company’s 2029 annual meeting of stockholders and until their respective successors are duly elected and qualified, or until their earlier death, resignation or removal.","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1759425/000119312526275811/0001193125-26-275811-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"director election"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2026-06-15"}],"fact_type":"shareholder_vote"},{"claim_id":"597d5c09af1dd679bc8ac42ea872e3c29ed61882","claim":"Mirum Pharmaceuticals, Inc. shareholders approved Advisory vote on executive compensation at the 2026-06-15 meeting.","evidence_excerpt":"The Company’s stockholders approved, on an advisory basis, the compensation of the Company’s named executive officers as disclosed in the Proxy Statement for the Annual Meeting.","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1759425/000119312526275811/0001193125-26-275811-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"say on pay"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2026-06-15"}],"fact_type":"shareholder_vote"},{"claim_id":"9185909a8b793ffcb242917fc53c3a16b251a19c","claim":"Mirum Pharmaceuticals, Inc. shareholders approved Ratification of the selection of Ernst & Young LLP as independent registered public accounting firm for fiscal year 2026 at the 2026-06-15 meeting.","evidence_excerpt":"The Company’s stockholders ratified the selection by the Audit Committee of the Company’s Board of Directors of Ernst & Young LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026.","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1759425/000119312526275811/0001193125-26-275811-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"auditor ratification"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2026-06-15"}],"fact_type":"shareholder_vote"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}